A new research initiative in the UK is set to enhance treatment outcomes for drug-resistant epilepsy by leveraging artificial intelligence and anonymized healthcare data.

This collaborative effort involves Swansea University and King’s College London, with funding provided by a grant from the Medical Research Council.

Annee Amjad from the Epilepsy Research Institute has expressed strong support for the project, noting its alignment with critical research priorities in the field of epilepsy.

Drug-resistant epilepsy affects about 30% of the 600,000 individuals living with epilepsy in the UK, resulting in severe issues such as seizures, memory problems, and mood disorders.

Dr. Owen Pickrell from Swansea University highlighted the promising potential of integrating real-world clinical data with AI to significantly benefit those suffering from drug-resistant epilepsy.

The project brings together a diverse team of clinicians, data scientists, AI experts, and individuals with personal experiences of epilepsy to deepen the understanding and treatment of this condition.

Researchers plan to utilize advanced natural language processing and AI techniques to predict medication resistance and optimize treatment options for those affected.